bioRxivCell Biology
A novel microRNA-based strategy to expand the differentiation potency of stem cells
M. Salazar-Roa, M. Trakala, M. Alvarez-Fernandez, F. Valdes-Mora, C. Zhong, J. Munoz, Y. Yu, T. J. Peters, O. Grana Castro, R. Serrano, E. Zapatero-Solana, M. Abad, M. J. Bueno, M. Gomez de Cedron, J. Fernandez-Piqueras, M. Serrano, M. A. Blasco, D.-Z. Wang, S. J. Clark, J. C. Izpisua Belmonte, S. Ortega, M. Malumbres
Abstract
Full differentiation potential along with self-renewal capacity is a major property of pluripotent stem cells (PSCs). However, the differentiation capacity frequently decreases during expansion of PSCs in vitro. We show here that transient exposure to a single microRNA, expressed at early stages during normal development, improves the differentiation capacity of already-established murine and human PSCs. Short exposure to miR-203 in PSCs (miPSCs) results in expanded differentiation potency as well as improved efficiency in stringent assays such as tetraploid complementation and human-mouse interspecies chimerism. Mechanistically, these effects are mediated by direct repression of de novo DNA methyltransferases Dnmt3a and Dnmt3b, leading to transient and reversible erasing of DNA methylation. As a proof of concept, miR-203 improves differentiation and maturation of PSCs into cardiomyocytes in vitro as well as cardiac regeneration in vivo, after cardiac injury. These data support the use of transient exposure to miR-203 as a general and single method to reset the epigenetic memory in PSCs, and improve their use in regenerative medicine.
- organism: mouse
- organism: human
- assay: DNA methylation
- research focus: chromatin & epigenetic regulation
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Interrupted reprogramming into induced pluripotent stem cells does not rejuvenate human mesenchymal stromal cells
C. Goebel, R. Goetzke, … W. Wagner·bioRxiv·Jun 12, 2018
- Inhibition of Type I PRMTs Reforms Muscle Stem Cell Identity Enhancing their Therapeutic Capacity
Claudia Dominici, Oscar David Villarreal, … Stéphane Richard·eLifePeer-reviewed·Mar 3, 2023
- Transient let-7/miR-98 reprograms primed pluripotency to induce naivehuman PSCs
Yoshihiko Fujita, Moe Hirosawa, … Hirohide Saito·bioRxiv·Oct 14, 2025
- Musashi1 and its short C-terminal variants regulate pluripotency states in embryonic stem cells
Youwei Chen, Hailin Zhang, … Gufa Lin·bioRxiv·May 2, 2022
- Trajectory reconstruction identifies dysregulation of perinatal maturation programs in pluripotent stem cell-derived cardiomyocytes
S. Kannan, M. Miyamoto, … C. Kwon·bioRxiv·Jan 31, 2021
- Modulation of the JAK2-STAT3 pathway promotes expansion and maturation of human iPSCs-derived myogenic progenitor cells
Luca Caputo, Cedomir Stamenkovic, … Alessandra Sacco·Stem Cell ReportsPeer-reviewed·Oct 30, 2025